Literature DB >> 1602296

Hepatotoxicity due to repeated intake of low doses of paracetamol.

L S Eriksson1, U Broomé, M Kalin, M Lindholm.   

Abstract

The cases of two patients with fulminant hepatic failure after intake of therapeutic doses (4-8 g) of paracetamol, and who were admitted to hospital for assessment for liver transplantation, are described. In both patients starvation, due to abdominal pain, nausea and vomiting or diarrhoea, was probably contributing to the toxic effect of the drug. One of the patients also had an excessive alcohol intake. Paracetamol should not be prescribed for patients with alcoholism or with low food intake.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1602296     DOI: 10.1111/j.1365-2796.1992.tb00976.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  20 in total

Review 1.  Emergency orthogeriatrics: concepts and therapeutic alternatives.

Authors:  Christopher R Carpenter; Michael E Stern
Journal:  Emerg Med Clin North Am       Date:  2010-11       Impact factor: 2.264

2.  Evaluation of the hepatroprotective and nephroprotective activities of Scrophularia hypericifolia growing in Saudi Arabia.

Authors:  Saleh I Alqasoumi
Journal:  Saudi Pharm J       Date:  2013-12-12       Impact factor: 4.330

Review 3.  Deaths from low dose paracetamol poisoning.

Authors:  S Bridger; K Henderson; E Glucksman; A J Ellis; J A Henry; R Williams
Journal:  BMJ       Date:  1998-06-06

4.  The impact of nationally distributed guidelines on the management of paracetamol poisoning in accident and emergency departments. National Poison Information Service.

Authors:  M C Bialas; R J Evans; A D Hutchings; G Alldridge; P A Routledge
Journal:  J Accid Emerg Med       Date:  1998-01

Review 5.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

6.  PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses.

Authors:  Liudmila L Mazaleuskaya; Katrin Sangkuhl; Caroline F Thorn; Garret A FitzGerald; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2015-08       Impact factor: 2.089

Review 7.  Can paracetamol (acetaminophen) be administered to patients with liver impairment?

Authors:  Kelly L Hayward; Elizabeth E Powell; Katharine M Irvine; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2015-12-25       Impact factor: 4.335

8.  n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis.

Authors:  L March; L Irwig; J Schwarz; J Simpson; C Chock; P Brooks
Journal:  BMJ       Date:  1994-10-22

9.  Patterns of acetaminophen use exceeding 4 grams daily in a hospitalized population at a tertiary care center.

Authors:  Jesse M Civan; Victor Navarro; Steven K Herrine; Jeffrey M Riggio; Paul Adams; Simona Rossi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-01

10.  Abnormal serum transaminases following therapeutic doses of acetaminophen in the absence of known risk factors.

Authors:  D Kwan; W R Bartle; S E Walker
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.